Artal Group S.A. Chimerix Inc Transaction History

Artal Group S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 09, 2019	SELL	$2.05 - $4.32 $1.02 Million - $2.16 Million	-500,000 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$1.79 - $3.12 $895,000 - $1.56 Million	-500,000 Reduced 50.0%	500,000 $1.05 Million
Q3 2018 Nov 09, 2018	BUY	$3.58 - $4.9 $1.79 Million - $2.45 Million	500,000 Added 100.0%	1,000,000 $3.89 Million
Q3 2017 Nov 08, 2017	BUY	$4.35 - $5.25 $2.18 Million - $2.63 Million	500,000	500,000 $2.63 Million

37M

52.7K

130K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $237M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.